Foghorn Therapeutics's total assets for Q4 2025 were $198.10M, a decrease of -3.35% from the previous quarter. FHTX total liabilities were $306.60M for the fiscal quarter, a 4.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.